Beijing Strong Biotechnologies Inc
Beijing Strong Biotechnologies,Inc. researches, develops, manufactures, and sells in-vitro diagnostics (IVD) products and services in China and internationally. The company offers biochemistry reagents, including liver, renal, lipid, cardiac, diabetes, special protein, tumor marker, pancreas, inorganic, inflammation, TDM, and other panels; and coagulation products, such as prothrombin time, activ… Read more
Beijing Strong Biotechnologies Inc (300406) - Total Liabilities
Latest total liabilities as of September 2025: CN¥1.30 Billion CNY
Based on the latest financial reports, Beijing Strong Biotechnologies Inc (300406) has total liabilities worth CN¥1.30 Billion CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Beijing Strong Biotechnologies Inc - Total Liabilities Trend (2011–2024)
This chart illustrates how Beijing Strong Biotechnologies Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Beijing Strong Biotechnologies Inc Competitors by Total Liabilities
The table below lists competitors of Beijing Strong Biotechnologies Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Tianjin Saixiang Technology Co Ltd
SHE:002337
|
China | CN¥676.36 Million |
|
Aclaris Therapeutics Inc
NASDAQ:ACRS
|
USA | $55.43 Million |
|
CIR S.p.A. - Compagnie Industriali Riunite
F:BN7
|
Germany | €1.64 Billion |
|
Krispy Kreme Inc
NASDAQ:DNUT
|
USA | $1.91 Billion |
|
Jiangsu Rutong Petro-Machinery
SHG:603036
|
China | CN¥164.64 Million |
|
Everlight Chemical Industrial Corp
TW:1711
|
Taiwan | NT$4.31 Billion |
|
First Foundation Inc.
NYSE:FFWM
|
USA | $10.99 Billion |
|
BFI Finance Indonesia Tbk
JK:BFIN
|
Indonesia | Rp14.54 Trillion |
Liability Composition Analysis (2011–2024)
This chart breaks down Beijing Strong Biotechnologies Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 11.66 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.32 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.25 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Beijing Strong Biotechnologies Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Beijing Strong Biotechnologies Inc (2011–2024)
The table below shows the annual total liabilities of Beijing Strong Biotechnologies Inc from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥1.44 Billion | -0.83% |
| 2023-12-31 | CN¥1.45 Billion | +8.19% |
| 2022-12-31 | CN¥1.34 Billion | -4.43% |
| 2021-12-31 | CN¥1.41 Billion | +160.34% |
| 2020-12-31 | CN¥540.20 Million | +195.05% |
| 2019-12-31 | CN¥183.09 Million | +12.65% |
| 2018-12-31 | CN¥162.52 Million | -34.64% |
| 2017-12-31 | CN¥248.65 Million | +199.26% |
| 2016-12-31 | CN¥83.09 Million | -4.01% |
| 2015-12-31 | CN¥86.56 Million | +50.68% |
| 2014-12-31 | CN¥57.44 Million | +28.88% |
| 2013-12-31 | CN¥44.57 Million | -4.78% |
| 2012-12-31 | CN¥46.81 Million | +66.97% |
| 2011-12-31 | CN¥28.04 Million | -- |